Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Neoplasms × DNA Methylation × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Leukemia 8 Leukemia, Myeloid, Acute 4 Congenital Abnormalities 4 Uterine Cervical Neoplasms 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Wilms Tumor 2 Squamous Intraepithelial Lesions 2 Sarcoma 2 Leukemia, Myelomonocytic, Acute 2 Leukemia, Monocytic, Acute 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Erythroblastic, Acute 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Testicular Neoplasms 1 Testicular Germ Cell Tumor 1 Small Cell Lung Carcinoma 1 Recurrence 1 Rectal Neoplasms 1 Ovarian Neoplasms 1 Neuroblastoma 1 Neoplasms 1 Myelodysplastic Syndromes 1 Melanoma 1 Leukemia, Eosinophilic, Acute 1 Leukemia, Basophilic, Acute 1 Kidney Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Surveys and Questionnaires 71 Blood Specimen Collection 45 Interviews as Topic 24 Data Collection 15 Radiotherapy 12 Observation 11 Magnetic Resonance Spectroscopy 11 Exercise 11 Watchful Waiting 9 Hematologic Tests 9 Drug Therapy 9 Quality of Life 8 Therapeutics 6 Specimen Handling 6 Focus Groups 6 Biopsy 6 Phlebotomy 5 Magnetic Resonance Imaging 5 Lapatinib 5 pembrolizumab 4 Trastuzumab 4 Standard of Care 4 Restraint, Physical 4 Palliative Care 4 Nivolumab 4 Neoadjuvant Therapy 4 Mental Status and Dementia Tests 4 Ipilimumab 4 High-Throughput Nucleotide Sequencing 4 Base Sequence 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05504772 2024-07-17

ZERO2

Australian & New Zealand Children's Haematology/Oncology Group

Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡